DEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM(TM) -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM(TM)-mRNA CANCER VACCINE PROGRAM BEGINS

EQS-News: Defence Therapeutics Inc.


/ Key word: Research Update





DEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM-mRNA... | April 11, 2023

Related Keywords

Vancouver ,British Columbia ,Canada ,Canadian ,Sebastien Plouffe ,Defence Therapeutics Inc ,Precedence Research ,Defence Therapeutics ,Defence Therapeutics Inc Stock Exchange ,News ,Information ,Press Release ,Defence ,Herapeutics ,Key ,Research ,Uccessfully ,Engineered ,Vaccum ,Vaccine ,Reating ,Few ,The ,N ,Ivo Dtc Ca24463v1013 ,